235 related articles for article (PubMed ID: 30718275)
1. Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis.
Liu Y; Xu X; Lin P; He Y; Zhang Y; Cao B; Zhang Z; Sethi G; Liu J; Zhou X; Mao X
J Biol Chem; 2019 Mar; 294(12):4572-4582. PubMed ID: 30718275
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth.
Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990
[TBL] [Abstract][Full Text] [Related]
3. USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis.
Shang Z; Zhao J; Zhang Q; Cao C; Tian S; Zhang K; Liu L; Shi L; Yu N; Yang S
J Biol Chem; 2019 Jun; 294(25):9844-9857. PubMed ID: 31073027
[TBL] [Abstract][Full Text] [Related]
4. WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation.
Liu H; Chen W; Liang C; Chen BW; Zhi X; Zhang S; Zheng X; Bai X; Liang T
Cancer Lett; 2015 Jun; 361(2):218-25. PubMed ID: 25749422
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival.
Schwickart M; Huang X; Lill JR; Liu J; Ferrando R; French DM; Maecker H; O'Rourke K; Bazan F; Eastham-Anderson J; Yue P; Dornan D; Huang DC; Dixit VM
Nature; 2010 Jan; 463(7277):103-7. PubMed ID: 20023629
[TBL] [Abstract][Full Text] [Related]
6. USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells.
Lu Q; Zhang FL; Lu DY; Shao ZM; Li DQ
Cancer Med; 2019 Nov; 8(15):6730-6740. PubMed ID: 31512408
[TBL] [Abstract][Full Text] [Related]
7. WP1130 attenuates cisplatin resistance by decreasing P53 expression in non-small cell lung carcinomas.
Wang X; Bao Y; Dong Z; Chen Q; Guo H; Ziang C; Shao J
Oncotarget; 2017 Jul; 8(30):49033-49043. PubMed ID: 28446729
[TBL] [Abstract][Full Text] [Related]
8. PBX homeobox 1 enhances hair follicle mesenchymal stem cell proliferation and reprogramming through activation of the AKT/glycogen synthase kinase signaling pathway and suppression of apoptosis.
Jiang Y; Liu F; Zou F; Zhang Y; Wang B; Zhang Y; Lian A; Han X; Liu Z; Liu X; Jin M; Wang D; Li G; Liu J
Stem Cell Res Ther; 2019 Aug; 10(1):268. PubMed ID: 31443676
[TBL] [Abstract][Full Text] [Related]
9. Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics.
Chen X; Lu D; Gao J; Zhu H; Zhou Y; Gao D; Zhou H
J Proteome Res; 2019 Jun; 18(6):2654-2665. PubMed ID: 31059266
[TBL] [Abstract][Full Text] [Related]
10. Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis.
Kapuria V; Peterson LF; Fang D; Bornmann WG; Talpaz M; Donato NJ
Cancer Res; 2010 Nov; 70(22):9265-76. PubMed ID: 21045142
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitinase ubiquitin-specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells.
Lu Q; Lu D; Shao ZM; Li DQ
Cancer Sci; 2019 Apr; 110(4):1268-1278. PubMed ID: 30689267
[TBL] [Abstract][Full Text] [Related]
12. Apigenin manipulates the ubiquitin-proteasome system to rescue estrogen receptor-β from degradation and induce apoptosis in prostate cancer cells.
Singh V; Sharma V; Verma V; Pandey D; Yadav SK; Maikhuri JP; Gupta G
Eur J Nutr; 2015 Dec; 54(8):1255-67. PubMed ID: 25408199
[TBL] [Abstract][Full Text] [Related]
13. β-catenin is regulated by USP9x and mediates resistance to TRAIL-induced apoptosis in breast cancer.
Ouyang W; Zhang S; Yang B; Yang C; Zhang J; Zhou F; Xie C
Oncol Rep; 2016 Feb; 35(2):717-24. PubMed ID: 26717875
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitylating enzyme USP9x regulates radiosensitivity in glioblastoma cells by Mcl-1-dependent and -independent mechanisms.
Wolfsperger F; Hogh-Binder SA; Schittenhelm J; Psaras T; Ritter V; Bornes L; Huber SM; Jendrossek V; Rudner J
Cell Death Dis; 2016 Jan; 7(1):e2039. PubMed ID: 26775694
[TBL] [Abstract][Full Text] [Related]
15. Deubiquitinase USP9x confers radioresistance through stabilization of Mcl-1.
Trivigno D; Essmann F; Huber SM; Rudner J
Neoplasia; 2012 Oct; 14(10):893-904. PubMed ID: 23097624
[TBL] [Abstract][Full Text] [Related]
16. Targeting of the deubiquitinase USP9X attenuates B-cell acute lymphoblastic leukemia cell survival and overcomes glucocorticoid resistance.
Zhou M; Wang T; Lai H; Zhao X; Yu Q; Zhou J; Yang Y
Biochem Biophys Res Commun; 2015 Apr; 459(2):333-339. PubMed ID: 25735983
[TBL] [Abstract][Full Text] [Related]
17. USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma.
Engel K; Rudelius M; Slawska J; Jacobs L; Ahangarian Abhari B; Altmann B; Kurutz J; Rathakrishnan A; Fernández-Sáiz V; Brunner A; Targosz BS; Loewecke F; Gloeckner CJ; Ueffing M; Fulda S; Pfreundschuh M; Trümper L; Klapper W; Keller U; Jost PJ; Rosenwald A; Peschel C; Bassermann F
EMBO Mol Med; 2016 Aug; 8(8):851-62. PubMed ID: 27317434
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of USP9X induces apoptosis in FLT3-ITD-positive AML cells cooperatively by inhibiting the mutant kinase through aggresomal translocation and inducing oxidative stress.
Akiyama H; Umezawa Y; Ishida S; Okada K; Nogami A; Miura O
Cancer Lett; 2019 Jul; 453():84-94. PubMed ID: 30946869
[TBL] [Abstract][Full Text] [Related]
19. Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer.
Wang S; Kollipara RK; Srivastava N; Li R; Ravindranathan P; Hernandez E; Freeman E; Humphries CG; Kapur P; Lotan Y; Fazli L; Gleave ME; Plymate SR; Raj GV; Hsieh JT; Kittler R
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4251-6. PubMed ID: 24591637
[TBL] [Abstract][Full Text] [Related]
20. Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor.
Liao Y; Liu N; Hua X; Cai J; Xia X; Wang X; Huang H; Liu J
Cell Death Dis; 2017 Feb; 8(2):e2585. PubMed ID: 28151478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]